Staten Biotechnology BV
1 clinical trials · Sponsor
◉ Watch Staten Biotechnology BV
| Record | Firm | Date |
|---|---|---|
| A First in Human Study of STT-5058, an Antibody That Binds ApoC3 (NCT04419688) | Staten Biotechnology BV | 2020-05-26 |
Track Staten Biotechnology BV automatically
Every clearance here is in the API, with alerts when new ones post.